Replies to post #361662 on Amarin Corp Plc (AMRN)

[oneragman]

Well...that's not impressive...but when has it been?

[Number sleven]

Raf, Thanks for the numbers. Interesting jump for Hikma, with an equivalent drop off for Dr-R.
Sleven,

[zmanindc]

The strength in GL is still so confusing and I can’t believe that many people are taking it for high Trigs. I think we lose plenty of scripts to GL and believe it’s the pharmacy that mentions it to the patient with the doctor clueless on the difference. Lovazza is hard on the stomach and I bet many don’t continue after the initial switch.

[concapk]

Raf

Can you post from PACER, the updated court docket on our case seeking relief on Rule 24/60......that Marjac just informed us .... GREAT job MARJAC....

[ralphey]

I have 8 Insurance denials for Vascepa sitting in my inbox right now -

[rafunrafun]

Scripts for week ending November 26, 2021 Thanksgiving

Overall drug TRx: -12.3%

Vascepa
TRx 68,451; -13.1% (-10,284) w/w; -4.7% y/y
NRx 28,737; -18.9% (-6,688) w/w; -5.8% y/y
Ref 39,714; -8.3% (-3,597) w/w; -3.9% y/y

Lovaza (Generic & Brand)
TRx 52,950; -16.6% (-10,515) w/w; -1.7% y/y
NRx 24,681; -20.7% (-6,436) w/w; -5.4% y/y
Ref 28,269; -12.6% (-4,080) w/w; +1.7% y/y

Generic Vascepa
TRx 19,470; -10.8% (-2,347) w/w; As % of total V: 22.1%
NRx 10,590; -12.6% (-1,531) w/w; As % of total V: 26.9%
Ref 8,880; -8.4% (-816) w/w; As % of total V: 18.3%

Generic Vascepa by Manufacturer
Hikma - TRx 11,547 (-2,184); Generic share 59.3%; Total V share 13.1%
Reddy - TRx 7,923 (-163); Generic share 40.7%; Total V share 9.0%

Vascepa + Generic Vascepa
TRx 87,922; -12.6% (-12,631)
NRx 39,328; -17.3% (-8,219)
Ref 48,594; -8.3% (-4,413)